| Characteristic | n (%) | |
| Site of disease | Pulmonary* | 2120 (60) |
| Extra-pulmonary | 1358 (38) | |
| Unknown | 85 (2) | |
| Diagnostic delay (days) | Median (IQR) | 37 (13–89) |
| Culture confirmed | Yes | 948 (27) |
| No | 2615 (73) | |
| Unknown | ||
| Species | Mycobacterium | 897 (25) |
| tuberculosis | ||
| M bovis | 3 (0.1) | |
| M africanum | 8 (0.2) | |
| Unknown | 2669 (74) | |
| Drug susceptibility | ||
| Isoniazid | Resistant | 78 (9.3) |
| Sensitive | 759 (90.7) | |
| Rifampicin | Resistant | 20 (2.4) |
| Sensitive | 817 (97.6) | |
| Ethambutol | Resistant | 7 (0.8) |
| Sensitive | 830 (99.2) | |
| Pyrazinamide | Resistant | 5 (0.6) |
| Sensitive | 830 (99.4) | |
| Multi-drug resistant | Resistant | 19 (2.3) |
| Sensitive | 818 (97.7) | |
*Includes patients with pulmonary and extra-pulmonary disease.
IQR, interquartile range.